Drug Information

Drug General Information
Drug ID
D0X1CB
Former ID
DNC001460
Drug Name
Trapoxin
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535274]
Structure
Download
2D MOL

3D MOL
Formula
C34H42N4O6
Canonical SMILES
C1CCN2C(C1)C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC<br />4=CC=CC=C4)CCCCCC(=O)C5CO5
InChI
1S/C34H42N4O6/c39-29(30-22-44-30)18-9-3-8-16-25-31(40)36-26(20-23-12-4-1-5-13-23)32(41)37-27(21-24-14-6-2-7-15-24)34(43)38-19-11-10-17-28(38)33(42)35-25/h1-2,4-7,12-15,25-28,30H,3,8-11,16-22H2,(H,35,42)(H,36,40)(H,37,41)/t25-,26-,27-,28+,30-/m0/s1
InChIKey
GXVXXETYXSPSOA-UFEOFEBPSA-N
CAS Number
CAS 133155-89-2
PubChem Compound ID
121875
PubChem Substance ID
10239842, 29302372, 50064353, 53080376, 104414481, 135077388, 142746422, 223736345, 230681897, 241032031, 249150892
Target and Pathway
Target(s) Histone deacetylase Target Info Inhibitor [535274]
References
Ref 535274Histone deacetylase as a new target for cancer chemotherapy. Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S20-6.
Ref 535274Histone deacetylase as a new target for cancer chemotherapy. Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S20-6.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.